GB0526038D0 - Immunogenic composition - Google Patents

Immunogenic composition

Info

Publication number
GB0526038D0
GB0526038D0 GB0526038A GB0526038A GB0526038D0 GB 0526038 D0 GB0526038 D0 GB 0526038D0 GB 0526038 A GB0526038 A GB 0526038A GB 0526038 A GB0526038 A GB 0526038A GB 0526038 D0 GB0526038 D0 GB 0526038D0
Authority
GB
United Kingdom
Prior art keywords
immunogenic composition
immunogenic
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0526038A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
GlaxoSmithKline Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GlaxoSmithKline Biologicals SA filed Critical GlaxoSmithKline Biologicals SA
Priority to GB0526038A priority Critical patent/GB0526038D0/en
Publication of GB0526038D0 publication Critical patent/GB0526038D0/en
Priority to PCT/EP2006/069944 priority patent/WO2007071692A2/en
Priority to CA 2634898 priority patent/CA2634898A1/en
Priority to US12/097,820 priority patent/US20080311146A1/en
Priority to EP06830724.8A priority patent/EP1962890B1/en
Priority to JP2008546433A priority patent/JP5780693B2/ja
Priority to ES06830724.8T priority patent/ES2558703T3/es
Priority to JP2013117514A priority patent/JP2013215197A/ja
Priority to US14/598,221 priority patent/US20150125481A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/085—Staphylococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB0526038A 2005-12-21 2005-12-21 Immunogenic composition Ceased GB0526038D0 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
GB0526038A GB0526038D0 (en) 2005-12-21 2005-12-21 Immunogenic composition
PCT/EP2006/069944 WO2007071692A2 (en) 2005-12-21 2006-12-19 Immunogenic composition
CA 2634898 CA2634898A1 (en) 2005-12-21 2006-12-19 Immunogenic composition
US12/097,820 US20080311146A1 (en) 2005-12-21 2006-12-19 Immunogenic Composition
EP06830724.8A EP1962890B1 (en) 2005-12-21 2006-12-19 Immunogenic composition
JP2008546433A JP5780693B2 (ja) 2005-12-21 2006-12-19 免疫原性組成物
ES06830724.8T ES2558703T3 (es) 2005-12-21 2006-12-19 Composición inmunógena
JP2013117514A JP2013215197A (ja) 2005-12-21 2013-06-04 免疫原性組成物
US14/598,221 US20150125481A1 (en) 2005-12-21 2015-01-15 Immunogenic Composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0526038A GB0526038D0 (en) 2005-12-21 2005-12-21 Immunogenic composition

Publications (1)

Publication Number Publication Date
GB0526038D0 true GB0526038D0 (en) 2006-02-01

Family

ID=35840898

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0526038A Ceased GB0526038D0 (en) 2005-12-21 2005-12-21 Immunogenic composition

Country Status (7)

Country Link
US (2) US20080311146A1 (https=)
EP (1) EP1962890B1 (https=)
JP (2) JP5780693B2 (https=)
CA (1) CA2634898A1 (https=)
ES (1) ES2558703T3 (https=)
GB (1) GB0526038D0 (https=)
WO (1) WO2007071692A2 (https=)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0610776D0 (en) * 2006-05-31 2006-07-12 Univ Bath Novel applications for staphylococcus aureus Sbi protein
EP2099932A4 (en) 2006-12-06 2009-11-18 Repligen Corp NUCLEIC ACIDS ENCODING THE RECOMBINANT PROTEIN A
ES2784957T3 (es) 2009-04-03 2020-10-02 Univ Chicago Composiciones y métodos relacionados con variantes de la proteína A (SPA)
MX2011010735A (es) 2009-04-14 2012-01-25 Novartis Ag Composiciones para inmunizacion contra staphylococcus aureus.
US8974799B2 (en) 2009-09-30 2015-03-10 Novartis Ag Conjugation of Staphylococcus aureus type 5 and type 8 capsular polysaccharides
BR112012010223A2 (pt) 2009-10-30 2016-12-06 Novartis Ag purificação de staphylococcus aureus tipo 5 e tipo 8 sacarídeos capsulares
JP6002128B2 (ja) 2010-07-02 2016-10-05 ザ・ユニバーシティ・オブ・シカゴＴｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｃｈｉｃａｇｏ プロテインＡ（ＳｐＡ）変種に関連する組成物および方法
US9095540B2 (en) * 2010-09-09 2015-08-04 The University Of Chicago Methods and compositions involving protective staphylococcal antigens
WO2013096948A1 (en) 2011-12-23 2013-06-27 Lydon Nicholas B Immunoglobulins and variants directed against pathogenic microbes
US9988439B2 (en) 2011-12-23 2018-06-05 Nicholas B. Lydon Immunoglobulins and variants directed against pathogenic microbes
CN102698260B (zh) * 2012-04-20 2013-09-25 西北农林科技大学 预防山羊葡萄球菌乳房炎的亚单位疫苗的制备方法及应用
WO2015073801A1 (en) * 2013-11-14 2015-05-21 Duke University Tetanus toxoid and ccl3 improve dc vaccines
AU2014359277B2 (en) * 2013-12-04 2017-10-26 Glaxosmithkline Biologicals S.A. Prevention of Staphylococcus aureus infections by glycoprotein vaccines synthesized in Escherichia coli
CN103694322B (zh) * 2013-12-09 2016-08-17 成都欧林生物科技股份有限公司 金黄色葡萄球菌SpA5突变体及其制备方法和应用
BE1022857A1 (fr) 2014-03-26 2016-09-27 Glaxosmithkline Biologicals Sa Immunisation contre staphylococcus aureus
GB201619965D0 (en) * 2016-11-25 2017-01-11 Univ Of Bath The Immunogenic compositions comprising sbi protein and uses thereof
GB201802339D0 (en) 2018-02-13 2018-03-28 Glaxosmithkline Biologicals Sa Immunogenic composition
MX2021013833A (es) 2019-05-14 2022-03-17 Univ Chicago Metodos y composiciones que comprenden variantes de la proteina a de estafilococos (spa).
EP3777884A1 (en) * 2019-08-15 2021-02-17 GlaxoSmithKline Biologicals S.A. Immunogenic composition
US20230210967A1 (en) * 2020-04-23 2023-07-06 Brightpath Biotherapeutics Co., Ltd. Improved peptide vaccine
WO2024129976A2 (en) * 2022-12-14 2024-06-20 Scribe Therapeutics Inc. Particle delivery systems

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5571514A (en) * 1987-06-01 1996-11-05 Alfa Laval Ab Fibronectin binding protein as well as its preparation
SE9704141D0 (sv) * 1997-11-12 1997-11-12 Sbl Vaccin Ab New protein and nucleotide sequence, encoding said protein
EP1121149A4 (en) 1998-08-31 2002-03-20 Inhibitex Inc IMMUNOTHERAPEUTICS AGAINST STAPHYLOCOCCUS USING DONOR SELECTION AND DONOR STIMULATION
KR100644953B1 (ko) 1998-08-31 2006-11-10 인히비텍스, 인코포레이티드 다성분 백신
AU6033299A (en) 1998-09-14 2000-04-03 Nabi Compositions of beta-glucans and specific igiv
US7098383B2 (en) * 2000-12-19 2006-08-29 Sembiosys Genetics Inc. Methods for the production of multimeric immunoglobulins, and related compositions
GB0107661D0 (en) * 2001-03-27 2001-05-16 Chiron Spa Staphylococcus aureus
BRPI0408167B1 (pt) * 2003-03-07 2014-10-21 Wyeth Corp Conjugados de polissacarídeo-proteína veículo adesina da superfície estafilocócica para imunização contra infecções nosocomiais
US20050137220A1 (en) * 2003-07-23 2005-06-23 Pharmacia Corporation Beta-carboline compounds and analogues thereof as mitogen-activated protein kinase-activated protein kinase-2 inhibitors
ATE457737T1 (de) * 2003-07-24 2010-03-15 Merck & Co Inc Polypeptide zur induktion einer schützenden immunantwort gegen staphylococcus aureus
KR20070058631A (ko) * 2004-09-22 2007-06-08 글락소스미스클라인 바이오로지칼즈 에스.에이. 면역원성 조성물

Also Published As

Publication number Publication date
JP5780693B2 (ja) 2015-09-16
WO2007071692A2 (en) 2007-06-28
WO2007071692A3 (en) 2007-09-13
CA2634898A1 (en) 2007-06-28
US20150125481A1 (en) 2015-05-07
US20080311146A1 (en) 2008-12-18
ES2558703T3 (es) 2016-02-08
EP1962890A2 (en) 2008-09-03
JP2013215197A (ja) 2013-10-24
JP2009520758A (ja) 2009-05-28
EP1962890B1 (en) 2015-11-11

Similar Documents

Publication Publication Date Title
AP2436A (en) Immunogenic composition
IL181825A0 (en) Immunogenic composition
IL227934A0 (en) Immunogenic preparation
ZA200709518B (en) Vaccine composition
GB0526038D0 (en) Immunogenic composition
ZA200710909B (en) Immunogenic composition
EP1847249A4 (en) hair dye
GB0421079D0 (en) Immunogenic composition
GB0606416D0 (en) Immunogenic composition
ZA200710854B (en) Immunogenic composition
GB0524204D0 (en) Immunogenic composition
GB0526040D0 (en) Immunogenic composition
GB0515556D0 (en) Immunogenic composition
GB0503143D0 (en) Immunogenic composition
GB0526041D0 (en) Immunogenic composition
GB0502569D0 (en) Vaccine composition
GB0421081D0 (en) Immunogenic composition
GB0421082D0 (en) Immunogenic composition
GB0421078D0 (en) Immunogenic composition
GB0606417D0 (en) Immunogenic composition
ZA200702752B (en) Immunogenic compositions
HK1116408A (en) Immunogenic composition
HK1116412A (en) Immunogenic composition
GB0509563D0 (en) Composition
GB0515907D0 (en) Composition

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)